Correlation Engine 2.0
Clear Search sequence regions

  • 2 4 d (3)
  • activity (4)
  • adenosine receptor (3)
  • cells (1)
  • CHO (1)
  • cricetulus (1)
  • cyclic amp (3)
  • diamines (3)
  • drug design (1)
  • female (1)
  • humans (1)
  • ligands (1)
  • mice (1)
  • pain (3)
  • pyrimidines (2)
  • receptor (5)
  • thiazoles (2)
  • vitro (2)
  • Sizes of these terms reflect their relevance to your search.

    In this study, we describe the design and synthesis of new N5-substituted-2-(2-furanyl) thiazolo[5,4-d]pyrimidine-5,7-diamines (2-18) and their pharmacological characterization as A2A adenosine receptor (AR) antagonists by using in vitro and in vivo assays. In competition binding experiments two derivatives (13 and 14) emerged as outstanding ligands showing two different affinity values (KH and KL) for the hA2A receptor with the high affinity KH value in the femtomolar range. The in vitro functional activity assays, performed by using cyclic AMP experiments, assessed that they behave as potent inverse agonists at the hA2A AR. Compounds 13 and 14 were evaluated for their antinociceptive activity in acute experimental models of pain showing an effect equal to or greater than that of morphine. Overall, these novel inverse agonists might represent potential drug candidates for an alternative approach to the management of pain.


    Flavia Varano, Daniela Catarzi, Fabrizio Vincenzi, Marco Betti, Matteo Falsini, Annalisa Ravani, Pier Andrea Borea, Vittoria Colotta, Katia Varani. Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity. Journal of medicinal chemistry. 2016 Dec 08;59(23):10564-10576

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 27933962

    View Full Text